JP2019520332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520332A5 JP2019520332A5 JP2018561467A JP2018561467A JP2019520332A5 JP 2019520332 A5 JP2019520332 A5 JP 2019520332A5 JP 2018561467 A JP2018561467 A JP 2018561467A JP 2018561467 A JP2018561467 A JP 2018561467A JP 2019520332 A5 JP2019520332 A5 JP 2019520332A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- peptide
- cmv
- apc
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023020200A JP2023071724A (ja) | 2016-05-23 | 2023-02-13 | Ｃｍｖエピトープ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662340223P | 2016-05-23 | 2016-05-23 | |
| US62/340,223 | 2016-05-23 | ||
| PCT/IB2017/000849 WO2017203370A2 (en) | 2016-05-23 | 2017-05-23 | Cmv epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023020200A Division JP2023071724A (ja) | 2016-05-23 | 2023-02-13 | Ｃｍｖエピトープ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019520332A JP2019520332A (ja) | 2019-07-18 |
| JP2019520332A5 true JP2019520332A5 (https=) | 2020-07-02 |
Family
ID=60412168
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018561467A Pending JP2019520332A (ja) | 2016-05-23 | 2017-05-23 | Ｃｍｖエピトープ |
| JP2023020200A Pending JP2023071724A (ja) | 2016-05-23 | 2023-02-13 | Ｃｍｖエピトープ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023020200A Pending JP2023071724A (ja) | 2016-05-23 | 2023-02-13 | Ｃｍｖエピトープ |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20200316119A1 (https=) |
| EP (1) | EP3463400A4 (https=) |
| JP (2) | JP2019520332A (https=) |
| CN (1) | CN109475579A (https=) |
| AU (2) | AU2017271136A1 (https=) |
| CA (1) | CA3025234A1 (https=) |
| WO (1) | WO2017203370A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200308279A1 (en) | 2017-10-06 | 2020-10-01 | Oslo Universitetssykehus Hf | Chimeric antigen receptors |
| AU2019268545A1 (en) * | 2018-05-18 | 2020-12-10 | The Council Of The Queensland Institute Of Medical Research | Adoptive T-cell therapy for CMV infection and CMV-associated diseases |
| ES3000183T3 (en) | 2018-09-10 | 2025-02-27 | Atara Biotherapeutics Inc | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto |
| IL291937A (en) * | 2019-10-09 | 2022-06-01 | Council Queensland Inst Medical Res | Direct link to epha3 and its uses |
| WO2021217206A1 (en) * | 2020-04-28 | 2021-11-04 | The Council Of The Queensland Institute Of Medical Research | Human cytomegalovirus polyepitope vaccine composition |
| CN111875698B (zh) * | 2020-07-29 | 2021-11-05 | 广州呈源生物免疫技术有限公司 | 靶向hcmv的tcr及其获得方法和应用 |
| KR102769935B1 (ko) * | 2021-03-30 | 2025-02-19 | 한국과학기술원 | 펩타이드-mhc에 대한 t 세포 활성의 예측 방법 및 분석장치 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE497971T1 (de) * | 1999-06-04 | 2011-02-15 | Florian Kern | Peptide zur vakzinierung gegen das humane cmv |
| DE10009341A1 (de) * | 2000-02-22 | 2001-09-06 | Florian Kern | Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| AUPR593101A0 (en) * | 2001-06-26 | 2001-07-19 | Council Of The Queensland Institute Of Medical Research, The | Cytomegalovirus t cell epitopes |
| DE602004021260D1 (de) * | 2003-07-11 | 2009-07-09 | Alphavax Inc | Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren |
| US7976845B2 (en) * | 2004-11-29 | 2011-07-12 | The Council Of The Queensland Institute Of Medical Research | Human cytomegalovirus immunotherapy |
| AU2012227280B2 (en) * | 2004-11-29 | 2016-09-22 | The Council Of The Queensland Institute Of Medical Research | Human cytomegalovirus immunotherapy |
| TW201000119A (en) * | 2008-06-10 | 2010-01-01 | Oncotherapy Science Inc | MYBL2 epitope peptides and vaccines containing the same |
| US20110136896A1 (en) * | 2008-08-01 | 2011-06-09 | Tong-Ming Fu | Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| WO2010037397A1 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cmv immune monitoring |
| GB0917094D0 (en) * | 2009-09-29 | 2009-11-11 | Ucl Biomedica Plc | T-cell receptor |
| PT2812431T (pt) * | 2012-02-09 | 2019-10-18 | Baylor College Medicine | Pepmixes para gerar ctls multivirais com larga especifidade |
| EP2849779B1 (en) * | 2012-05-16 | 2021-01-06 | Adelaide Research & Innovation Pty Ltd. | Cellular vaccine and method of inducing an immune response in a subject |
| GB201312133D0 (en) * | 2013-07-05 | 2013-08-21 | Univ Birmingham | Immunotherapy |
| US9757446B2 (en) * | 2014-03-17 | 2017-09-12 | Flugen, Inc. | Influenza virus vectors and uses therefor |
-
2017
- 2017-05-23 JP JP2018561467A patent/JP2019520332A/ja active Pending
- 2017-05-23 CA CA3025234A patent/CA3025234A1/en active Pending
- 2017-05-23 AU AU2017271136A patent/AU2017271136A1/en not_active Abandoned
- 2017-05-23 CN CN201780045358.8A patent/CN109475579A/zh active Pending
- 2017-05-23 WO PCT/IB2017/000849 patent/WO2017203370A2/en not_active Ceased
- 2017-05-23 US US16/303,677 patent/US20200316119A1/en not_active Abandoned
- 2017-05-23 EP EP17802274.5A patent/EP3463400A4/en active Pending
-
2023
- 2023-02-13 JP JP2023020200A patent/JP2023071724A/ja active Pending
- 2023-03-01 AU AU2023201279A patent/AU2023201279A1/en active Pending
-
2024
- 2024-08-08 US US18/798,113 patent/US20250127874A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520332A5 (https=) | ||
| JP6612963B2 (ja) | 腫瘍抗原を直接認識するために組換えｔ細胞レセプターを使用するための組成物及び方法 | |
| TWI776160B (zh) | 用於不同類型癌症免疫治療的非經典來源的肽和肽組合 | |
| WO2022068850A1 (zh) | Kras突变特异性t细胞受体筛选及抗肿瘤用途 | |
| Kim et al. | Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T-and B-cell responses | |
| TWI722662B (zh) | 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架 | |
| CN108778291B (zh) | 包含重组t细胞受体的组合物和文库以及使用重组t细胞受体的方法 | |
| TW201720842A (zh) | 用於抗cll及其他癌症之免疫治療的新穎胜肽及胜肽組合物 | |
| TWI781104B (zh) | 新型肽、肽組合物作為靶標以及用於膽囊癌、膽管癌和其他癌症免疫治療 | |
| TW201734036A (zh) | 用於nhl和其他癌症免疫治療的新型肽和肽組合物 | |
| TW201726723A (zh) | 用於對抗多種癌症的免疫療法的新胜肽及胜肽組合 | |
| CN109997041A (zh) | 人白细胞抗原限制的γδT细胞受体及其使用方法 | |
| TW201311895A (zh) | 用於胰臟癌之樹突細胞（ｄｃ）－疫苗療法 | |
| IL309003A (en) | Novel peptides, combination of peptides and scaffolds for use in immunothera-peutic treatment of various cancers | |
| TWI374031B (https=) | ||
| JP2019516768A5 (https=) | ||
| TW202300510A (zh) | 用於對抗多種癌症的免疫療法的新胜肽及胜肽組合 | |
| US20190374627A1 (en) | Target peptides for cancer therapy and diagnostics | |
| Bright et al. | SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients | |
| WO2016093243A9 (ja) | 腫瘍抗原ペプチド | |
| TW202140534A (zh) | 個人化醫藥 | |
| CN114853880A (zh) | Wt1抗原特异性t细胞受体及其抗肿瘤用途 | |
| JP2021511054A5 (https=) | ||
| Godet et al. | An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context | |
| Dlamini et al. | Current immunotherapeutic treatments in colon cancer |